Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.5 (EPT/RI) - Alternative Income REIT Plc
-
Form 8.5 (EPT/RI)-Gamma Communications Plc
-
AgentQuant Secures Dual SEC and MSB Registrations, Solidifying Compliance Foundation
-
-
Form 8.5 (EPT/RI)-Gooch & Housego plc
-
Forex Expo Dubai to Take Place as Scheduled on 22–23 September 2026
-
RESULT OF RIKSBANK CERTIFICATE SALE
-
Autheo Brings THEO to Robinhood Chain as Two Visions of Convergence Meet
-
Prophecy Launches AI Data Prep Tools to Close the Gap Between AI Investment and AI Results
-
Timo, an In-Car AI Social Robot, Is Coming to Kickstarter to Make Everyday Drives More Interactive and Fun
-
From Smart Massage to Proactive Wellness: SKG Expands Its Wearable Health Portfolio at IFA 2026
-
GHO Capital appoints Vivid Sehgal as Operating Partner
-
Crypto Wealth Holds Up in 2026 as Bitcoin Retreats from Record Highs
-
Transactions in connection with share buy-back program
-
New Multi-Site Validation Study Published by Panakeia Reinforces Scalability of AI Multi-Omics Platform
-
Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026
-
Unmasking Fraud: Verisk Releases Fraud Discovery, connecting intelligence, analytics and investigations in one powerful fraud platform
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
Investeringsforeningen Carnegie Wealth Management – Forløb af ekstraordinær generalforsamling
-
Rubis: Availability of the 2026 half-year financial report
-
Global Power Solutions Announces appointment of Lyle McChesney as Strategic Advisor.
-
Magnite Launches First Agentic Campaign in EMEA With Amnet France
-
Purna Pharmaceuticals Strengthens Leadership Team With Appointment of Industry Veterans
-
Brookfield Selected by Nuclear Liabilities Fund for Multi-Decade Investment Mandate
-
PannTheraPi Receives ANSM Approval to Advance PTI5803 into Phase 2a in Focal Cortical Dysplasia
-
Cytospire Therapeutics Appoints Highly Experienced Immuno-Oncology Leader, Sumeet Ambarkhane, M.D., as Chief Medical Officer
-
Nokia launches industry-first initiative to help operators accelerate network innovation in the AI era
-
EDF: EDF announces its intention to exercise its option to redeem hybrid bonds EDF launches a partial tender offer on an outstanding series of hybrid notes
-
EDF: EDF announces its intention to launch an issue of new green hybrid notes
-
NOTICE CONVENING THE EXTRAORDINARY GENERAL MEETING OF MARTELA CORPORATION
-
INSIDE INFORMATION: Martela is planning a directed share issue of EUR 5–8 million and the combination of its share series
-
LEADING EDGE MATERIALS DRILLS NEAR-MINE TO TEST FOR A LARGER REGIONAL GRAPHITE SYSTEM AT WOXNA, SWEDEN
-
Most organizations say full digital sovereignty is an unrealistic goal as businesses prioritize resilience over total independence
-
Campine acquires Flamaway Group, expanding its flame retardant activities by more than 50%
-
ASML and TSMC Announce Initiative to Pioneer Industry Transition to Large-Format Photomasks for High NA EUV
-
PRESS RELEASE: CMB.TECH announces special general meeting on 8 October 2026
-
Pragmatic Semiconductor Appoints Dr. Paul James as Executive Vice President Manufacturing & Operations
-
Lerøy Seafood Group ASA – Green bond mandate announcement
-
Agreement signed on the sale of shares in UAB Litagra
-
Rapid Nutrition Reports 227.5% H1 Revenue Growth as Group Enters Transformational Second Half
-
Aktsiaselts Infortar subsidiary OÜ Infortar Agro to acquire a 100% shareholding in Lithuanian agricultural company Litagra
-
NBPE Announces Transaction in Own Shares
-
Pragmatic Semiconductor Appoints Dr. Paul James as Executive Vice President Manufacturing & Operations
-
Progress on share buyback programme
-
Equinor ASA: Share buy-back – third tranche for 2026
-
Greywolf Therapeutics doses first participants with axSpA in novel ERAP1 inhibitor trial
-
Latest Crypto News: Apeing’s Crypto Presale Set to Go Live in Less Than 24 Hours as Ethereum Tests $2,520
-
The 24th China International Equipment Manufacturing Exposition Kicks off in Shenyang
-
AB “Novaturas” has entered into agreements to transfer its own shares, exercising the options granted to employees in 2022 and 2023
-
Transgene and ProBioGen Expand Strategic Partnership with Additional License Agreement for AGE1.CR.pIX Cell Line
